Maternal exposure to phthalates and nanoplastics, isolated or combined: Impacts on placental structure, development, and antioxidant defense as a trigger for maternal-fetal adversities
{"title":"Maternal exposure to phthalates and nanoplastics, isolated or combined: Impacts on placental structure, development, and antioxidant defense as a trigger for maternal-fetal adversities","authors":"Natália Magosso , Patrick Vieira Souza , Mirella Franco Moreira , Vanessa Aguiar Rocha , Matheus Naia Fioretto , Victória Cristina Pinha , Gabriel Aquino Maia , Vinícius Luís Rocha S. Maria , Luisa Annibal Barata , Giovanna Fachetti Frigoli , Glaura Scantamburlo Alves Fernandes , Arielle Cristina Arena , Wellerson Rodrigo Scarano","doi":"10.1016/j.reprotox.2025.108930","DOIUrl":null,"url":null,"abstract":"<div><div>The placenta is an essential maternal-fetal organ for the healthy development of the fetus, linking maternal and fetal circulations. Endocrine disrupting chemicals (EDCs), such as phthalates derived from plastic residues, may impair offspring development and increase the risk of metabolic disorders. Plastics also degrade into microplastics (MPs) and nanoplastics (NPs), which can cross the placenta, carrying EDCs and impacting fetal development. The objective of this study was to investigate whether gestational exposure to a phthalate mixture (PM) and NPs interferes with the maternal-fetal interface, altering female reproductive efficiency and placental morphophysiology. Pregnant SD rats were divided into 6 groups: CTR(control; vehicle), T1(20 μg/kg/day-PM), T2(200 mg/kg/day-PM), T3(1 mg/kg/day NPs-100nm), T4(20 μg/kg/dayPM+1 mg/kg/day-NPs-100nm), and T5(200 mg/kg/day-PM+1 mg/kg/day-NPs-100 nm). Treatment was administered orally from gestational day 5 (GD5) to GD20. At GD20, 5–8 rats from each group were anesthetized and underwent laparotomy, and blood, ovaries, uterus, and placentas were analyzed. There was an increase in pre-implantation loss in T3, T4 and T5 groups, a reduction in placental weight, and an increase in placental efficiency in male offspring in T3 group. An increase in the number of fetuses small for gestational age was observed in T3 and T5 vs. C. Furthermore, the treatment caused an increase in the expression of targets related to trophoblast cell differentiation in T5, and growth factors related to angiogenesis in the placenta in T3 and T4 groups. There was a decrease in TBARS, SOD, and GSTpi levels in T2, while CAT increased in T3, suggesting that these pollutants modulate placental gene expression and energy metabolism.</div></div>","PeriodicalId":21137,"journal":{"name":"Reproductive toxicology","volume":"135 ","pages":"Article 108930"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive toxicology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0890623825001017","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"REPRODUCTIVE BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The placenta is an essential maternal-fetal organ for the healthy development of the fetus, linking maternal and fetal circulations. Endocrine disrupting chemicals (EDCs), such as phthalates derived from plastic residues, may impair offspring development and increase the risk of metabolic disorders. Plastics also degrade into microplastics (MPs) and nanoplastics (NPs), which can cross the placenta, carrying EDCs and impacting fetal development. The objective of this study was to investigate whether gestational exposure to a phthalate mixture (PM) and NPs interferes with the maternal-fetal interface, altering female reproductive efficiency and placental morphophysiology. Pregnant SD rats were divided into 6 groups: CTR(control; vehicle), T1(20 μg/kg/day-PM), T2(200 mg/kg/day-PM), T3(1 mg/kg/day NPs-100nm), T4(20 μg/kg/dayPM+1 mg/kg/day-NPs-100nm), and T5(200 mg/kg/day-PM+1 mg/kg/day-NPs-100 nm). Treatment was administered orally from gestational day 5 (GD5) to GD20. At GD20, 5–8 rats from each group were anesthetized and underwent laparotomy, and blood, ovaries, uterus, and placentas were analyzed. There was an increase in pre-implantation loss in T3, T4 and T5 groups, a reduction in placental weight, and an increase in placental efficiency in male offspring in T3 group. An increase in the number of fetuses small for gestational age was observed in T3 and T5 vs. C. Furthermore, the treatment caused an increase in the expression of targets related to trophoblast cell differentiation in T5, and growth factors related to angiogenesis in the placenta in T3 and T4 groups. There was a decrease in TBARS, SOD, and GSTpi levels in T2, while CAT increased in T3, suggesting that these pollutants modulate placental gene expression and energy metabolism.
期刊介绍:
Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.
All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.